| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $25.1M | $20.5M | $21.8M |
| YoY Revenue Growth % | +22.4% | -5.7% | — |
| Gross Profit | $13.7M | $10.1M | — |
| Gross Margin % | 54.5% | 49.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$17.5M | -$10.8M | -$20.4M |
| Operating Margin % | -69.6% | -52.8% | -80.0% |
| Net Income (GAAP) | -$13.2M | -$10.6M | -$20.1M |
| EBITDA (Normalized) | -$17.1M | -$10.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$15.9M | -$13.0M | -$17.4M |
| Capital Expenditures (CapEx) | $486.0K | $45.0K | — |
| Free Cash Flow (FCF) | -$16.4M | -$13.0M | -$17.4M |
| FCF Margin % | -65.3% | -63.5% | -79.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $70.7M | $15.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $83.6M | $29.9M | — |